Akums Drugs and Pharmaceuticals Limited has announced that it will host an earnings conference call for its un-audited financial results for the third quarter of the fiscal year 2026 (Q3 FY26). The conference call is scheduled to take place on Monday, February 16, 2026, at 12:00 PM Indian Standard Time (IST). The call is being organized by Ambit Capital and will be moderated by Gaurav Tinani from Ambit Capital's Institutional Equities team. Company representatives attending the call will include Mr. Sanjeev Jain (Managing Director), Mr. Sandeep Jain (Managing Director), Mr. Sumeet Sood (Chief Financial Officer), and Mr. Sahil Maheshwari (Head Strategy). Dial-in details and registration information via DiamondPass have been provided for participants to join the call.
